Economic evaluation of a mammography-based breast cancer screening programme in Spain.

  1. Garuz, R. 3
  2. Forcén, T. 4
  3. Cabasés, J. 5
  4. Antoñanzas, F. 6
  5. Trinxet, C. 1
  6. Rovira, J. 1
  7. Antón, F. 26
  1. 1 Universitat de Barcelona
    info

    Universitat de Barcelona

    Barcelona, España

    ROR https://ror.org/021018s57

  2. 2 Hospital San Pedro
    info

    Hospital San Pedro

    Logroño, España

    ROR https://ror.org/031va0421

  3. 3 Instituto de Investigación Sanitaria Aragón
    info

    Instituto de Investigación Sanitaria Aragón

    Zaragoza, España

  4. 4 Navarre Institute of Health, Tafalla (Navarre), Spain
  5. 5 Universidad Pública de Navarra
    info

    Universidad Pública de Navarra

    Pamplona, España

    ROR https://ror.org/02z0cah89

  6. 6 Universidad de La Rioja
    info

    Universidad de La Rioja

    Logroño, España

    ROR https://ror.org/0553yr311

Zugehörigkeit anzeigen +
Zeitschrift:
European Journal of Public Health

ISSN: 1101-1262

Datum der Publikation: 1997

Ausgabe: 7

Nummer: 1

Seiten: 68-76

Art: Artikel

beta Ver similares en nube de resultados
SCOPUS: 2-s2.0-0030951203 WoS: WOS:A1997WZ15600012 GOOGLE SCHOLAR

Andere Publikationen in: European Journal of Public Health

Institutionelles Repository: lock_openOpen Access Editor

Zusammenfassung

The aim of the study was to perform a cost-effectiveness analysis of a breast cancer (BC) mammography screening programme, compared to a do-nothing alternative, in Spain. Screening consisted of a biennial mammography performed on all women 50-65 years old. A marginal analysis including women 45-49 years old was also performed. With the aid of a decision tree model, the numbers of BC cases diagnosed through screening, BC cases missed by screening and false-positive BC cases were calculated. Costs were calculated by feeding local data into Markovian models and the cost-effectiveness ratio calculation was performed in a computer spread sheet. A sensitivity analysis was also conducted. Results were presented in ECUs of 1993. The cost- effectiveness ratio per avoided death is 115,500 ECUs and per saved life year 7,300 ECUs. Including women 45-49 years old in the programme raises this ratio to 229,000 and 9,400 ECUs respectively. The sensitivity analysis showed the efficacy of mammography, compliance of the programme and screening costs to be the more sensitive variables.